MedPath

Effect of Vitamin d and Omega 3 on Osteocalcin

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Interventions
Dietary Supplement: vitamin D3
Dietary Supplement: omega-3 fatty acid
Dietary Supplement: vitamin D3 and omega-3 fatty acid
Other: control
Registration Number
NCT04005612
Lead Sponsor
Applied Science Private University
Brief Summary

Assessing the combined effect of omega-3 fatty acid and vitamin D 3 on plasma osteocalcin levels

Detailed Description

The data about effect of vitamin D3 (VD3) and omega-3 fatty acids(omega-3FA) on plasma levels of osteocalcin (OCN) are scarce and conflicting and nothing is published in the literature about the effect of the combination of VD3 and omega-3FA on the OCN levels.

This study was conducted to investigate effect of VD3 and omega-3FA alone and with each other on PLASMA OCN levels in females and males with vitamin D deficiency (VDD).

This randomized, controlled clinical trial was designed to test effects of 50,000 IU VD3 weekly and 300 mg omega-3FA daily for eight weeks,separately and with each other, on the plasma levels of OCN and 25-hydroxy vitamin D (25OHD).

This study was conducted during winter in 86 healthy Jordanian females and males with VDD with a mean age of (40± 10) years.

Fasting serum levels for 25OHD,OCN, PTH (parathyroid hormone),calcium, phosphate, ALT (alanine aminotransferase), and urea were assessed at baseline and the end of the trial .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Medical diagnosis of vitamin D deficiency (VD < 30 ng / ml).
Exclusion Criteria
  • People who previously diagnosed with any chronic disease such as kidney diseases were excluded from the study due to the effect of prolonged administration of VD3 on kidney stones formation.
  • People with bone disorders also excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
vitamin d3 groupcontrolweekly Dietary Supplement: Vitamin D3 50,000 IU Vitamin D3 / week for 8 weeks
vitamin d3 groupvitamin D3weekly Dietary Supplement: Vitamin D3 50,000 IU Vitamin D3 / week for 8 weeks
omega3-Fatty Acid groupomega-3 fatty acid1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily
omega3-Fatty Acid groupvitamin D3 and omega-3 fatty acid1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily
VD3 and Omega-3FA groupcontrol50,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3 FA) once daily
vitamin d3 groupomega-3 fatty acidweekly Dietary Supplement: Vitamin D3 50,000 IU Vitamin D3 / week for 8 weeks
vitamin d3 groupvitamin D3 and omega-3 fatty acidweekly Dietary Supplement: Vitamin D3 50,000 IU Vitamin D3 / week for 8 weeks
omega3-Fatty Acid groupvitamin D31000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily
omega3-Fatty Acid groupcontrol1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily
VD3 and Omega-3FA groupvitamin D3 and omega-3 fatty acid50,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3 FA) once daily
VD3 and Omega-3FA groupvitamin D350,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3 FA) once daily
VD3 and Omega-3FA groupomega-3 fatty acid50,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3 FA) once daily
Primary Outcome Measures
NameTimeMethod
vitamin d3 levels8 weeks

Plasma levels of 25-hydroxyvitamin D

osteocalcin levels8 weeks

plasma osteocalcin levels

Secondary Outcome Measures
NameTimeMethod
PTH8 weeks

Plasma concentrations of PTH

calcium8 weeks

plasma Ca levels

Trial Locations

Locations (1)

Applied Science University

🇯🇴

Amman, Jordan

© Copyright 2025. All Rights Reserved by MedPath